Skip to main content

Animations

MJFF Publications

4801 - 4810 of 6422 Results
Title
Year
  • Year
  • 2016
  • 2021
  • 2012
  • 2024
  • 2024
  • 2020
  • 2019
  • 2022
  • 2022
  • 2021
  • Summary Details
    OPEN
    Title: ALS‐linked protein disulfide isomerase variants cause motor dysfunction
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embj.201592224
    Citation Count: 108
  • Summary Details
    OPEN
    Title: Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13360
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.11.007
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mdc3.14264
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Benchmarking of a multi‐biomarker low‐volume panel for Alzheimer's disease and related dementia research
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14413
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease
    Journal Name: Molecular & Cellular Proteomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/mcp.ra120.002055
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic Stimulation
    Journal Name: Research
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.34133/2019/7109535
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Paper Spray Ionization Ion Mobility Mass Spectrometry of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s Disease
    Journal Name: JACS Au
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/jacsau.2c00300
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Brain and Cerebrospinal Fluid α‐Synuclein Real‐Time Quaking‐Induced Conversion Identifies Lewy Body Pathology in LRRK2‐PD
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29284
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines9050514
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.